Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients

  • STATUS
    Recruiting
  • End date
    Dec 21, 2022
  • participants needed
    300
  • sponsor
    National Cancer Center, Korea
Updated on 21 January 2021
diabetes
cancer
remission
lymphoma
treatment regimen
primary cancer
chop regimen

Summary

To assess chemotherapy related hyperglycemia in non-diabetic patients, the investigators will assess the incidence of hyperglycemia and analyze co-medications and risk factors.

Details
Condition Colorectal Cancer, Colorectal Cancer, Colon Cancer Screening, Colon cancer; rectal cancer, Lymphoma, Non-Hodgkin's Lymphoma, Cancer, Cancer/Tumors, Neoplasms, Cancer (Pediatric), Ewing's Family Tumors, Cancer, Breast Cancer, Breast Cancer, Malignant neoplasm of colon, Colon Cancer, Lymphoma, Non-Hodgkin's Lymphoma, Colon Cancer Screening, Cancer/Tumors, Colon cancer; rectal cancer, Breast Cancer Diagnosis, Ewing's Family Tumors, Cancer (Pediatric), Colon Cancer, Neoplasms, breast carcinoma, primary cancer, primary malignant neoplasm, colon carcinoma, malignancy, cancers, malignancies, malignant tumor, malignant tumors, cancer, breast, lymphomas
Treatment Chemotherapy
Clinical Study IdentifierNCT03062072
SponsorNational Cancer Center, Korea
Last Modified on21 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients with cancers (colorectal, breast) who treated with curative intents and ones with malignant lymphoma who are expected to achieve complete remission with chemotherapy (mainly, CHOP regimen)
Patients without history of diabetes mellitus
Normal glucose tolerance, as defined in the protocol

Exclusion Criteria

Patients with diabetes mellitus or hyperglycemia, as defined in the protocol
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note